Suven Life Sciences Limited | SUVEN | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Net Income
Net Income
1,356
1,955
1,587
-1,064
-775
Cash flow Operating Act...
Cash flow Operating Activities
1,0881,135355-1,938-960
Investments in PPE
Investments in PPE
-305-400-973-24-63
Cash flow Investing Act...
Net cash used for Investment Activities
-3,107-6-2792,056558
Dividend Paid
Dividend Paid
15323023000
Cash flow Financing Act...
Net cash provided by Financing Activities
-300-577-22527349
Cash at beginning of period
Cash at beginning of period
2,405872592147
Cash at end of period
Cash at end of period
8720311114793
Free Cash Flow
Free Cash Flow
783
734
-618
-1,962
-1,023